Jerry S. Wolinsky, MD

Jerry S. Wolinsky, MD
Bartels Family and Opal C. Rankin Professor of Neurology
Director, Multiple Sclerosis Research Group and MRI Analysis Center
The University of Texas Health Science Center at Houston
Houston, Texas

Jerry S. Wolinsky, MD, holds the Bartels Family and Opal C. Rankin Professor of Neurology and is a member of the faculty of the Graduate School of Biomedical Sciences at The University of Texas Health Science Center at Houston, where he also serves as director of the Multiple Sclerosis Research Group and the Magnetic Resonance Imaging Analysis Center.

Dr. Wolinsky received his medical doctorate in 1969 from The University of Illinois. Residency training in clinical neurology, a fellowship in experimental neuropathology, and a faculty appointment at the University of California San Francisco followed. While in San Francisco, his research interests focused on the pathogenesis of viral infections of the nervous system, and he began research on experimental therapeutics of infections of the central nervous system and multiple sclerosis (MS). He subsequently joined the faculties of The Johns Hopkins University School of Medicine and School of Hygiene and Public Health in 1978, before settling in Houston in 1983. In Baltimore, he expanded his investigations using molecular biology techniques and became increasingly interested in the primary and secondary immunopathogenesis of neural disease. He is currently active in the design, implementation, conduct, and analysis of clinical trials of MS and conducts basic and applied research in quantitative MRI and MR spectroscopic imaging in demyelinating diseases.

Dr. Wolinsky has served on review and advisory committees of the National Institutes of Health, the MS International Federation, the Food and Drug Administration, the Sylvia Lawry Centre for MS Research, and numerous pharmaceutical companies. He also served as Interim Dean of the University of Texas Medical School at Houston. Dr. Wolinsky currently oversees the centralized image analysis programs for the NINDS-sponsored CombiRx Trial and the sanofi-aventis clinical development studies of teriflunomide in MS. He is past chair of the Research Programs Advisory Committee, current chair of the National Clinical Advisory Board of the National MS Society, and current president of Americas Committee for Treatment and Research in MS (ACTRIMS). He is on the editorial board of Multiple Sclerosis and is recognized in Best Doctors in America and America’s Top Doctors. He has authored well over 250 publications dealing with issues of relevance to neurovirology and neuroimmunology, clinical trials, and the imaging of MS.